← Leaderboards
Simone Krebs
Sloan-Kettering Inst Can Research
$3,266,625
Attributed
$3,266,625
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $961.4K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,266,625 · 2
By mechanism
R37$2,834,491 · 1
R21$432,134 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Luis F Parada$23,930,635
- Jason Huse$6,410,852
- Prasad S. Adusumilli$7,809,681
- Lisa Bodei$1,419,480
- Jacob Houghton$1,773,649
Others in their field
Other Emerging Leaders on “Generations”
- Klaus Romero · Critical Path Institute$88,602,036
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ted Ross · University Of Georgia$70,992,558
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,130,757
- Scott Topper · Broad Institute, Inc.$60,777,399
- John Damon Chodera · Sloan-Kettering Inst Can Research$59,941,649
Research focus
GenerationsMalignant NeoplasmsClinical TranslationExhibitsIn VitroKineticsChimeric Antigen Receptor T CellsClinical ApplicationDoseEnsureImageBindingIn VivoBiodistributionAntigensCellsAffinityCell KillingAutoradiographyCytotoxicAblationDosimetryAntibodiesMonitor
Grant awards (7)
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture$529,244
R37 · FY2025 · CA · contact PI
IL13Ra2-targeted radioimmunotherapy for glioblastoma$432,134
R21 · FY2025 · CA · contact PI
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture$405,794
R37 · FY2024 · CA · contact PI
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture$155,995
R37 · FY2024 · CA · contact PI
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture$668,696
R37 · FY2023 · CA · contact PI
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture$551,690
R37 · FY2022 · CA · contact PI
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture$523,072
R37 · FY2021 · CA · contact PI